https://seetharamkandarpa.webnode.in/https://seetharamkandarpa.webnode.in/contact-me/https://seetharamkandarpa.webnode.in/news-/https://seetharamkandarpa.webnode.in/blog/https://seetharamkandarpa.webnode.in/keyinfo-/https://seetharamkandarpa.webnode.in/our-team/https://seetharamkandarpa.webnode.in/useful-information/https://seetharamkandarpa.webnode.in/about-me/https://seetharamkandarpa.webnode.in/gmp-videos/https://seetharamkandarpa.webnode.in/asq-cqa/https://seetharamkandarpa.webnode.in/asq-certification/asq-cpgp/https://seetharamkandarpa.webnode.in/knowledge-bank/https://seetharamkandarpa.webnode.in/asq-certification2/https://seetharamkandarpa.webnode.in/news/regulatory-updates/https://seetharamkandarpa.webnode.in/news/gmp-news/https://seetharamkandarpa.webnode.in/news/why-is-gmp-so-important-answers-from-the-fda-/https://seetharamkandarpa.webnode.in/news/glp-updates/https://seetharamkandarpa.webnode.in/news/government-regulatory-bodies-in-the-world/https://seetharamkandarpa.webnode.in/news/data-related-to-the-pharmacokinetics-and-pharmacodynamics-of-drugs/https://seetharamkandarpa.webnode.in/news/pharmacopoeias/https://seetharamkandarpa.webnode.in/news/patents-trade-mark-web-sources/https://seetharamkandarpa.webnode.in/news/gmp-regulations-worldwide/https://seetharamkandarpa.webnode.in/news/g-one-gmp-one-one-spot-for-all-gmp-links-required-in-our-jeevan/https://seetharamkandarpa.webnode.in/news/pharma-news/https://seetharamkandarpa.webnode.in/news/final-gdp-guideline-published-by-eu-commission/https://seetharamkandarpa.webnode.in/news/conducting-an-effective-meeting/https://seetharamkandarpa.webnode.in/news/india-issues-guidelines-for-certification-of-api-exports-to-eu-will-ema-accept-this-certification-/https://seetharamkandarpa.webnode.in/news/fda-answers-questions-related-to-user-fees-for-generic-drugs/https://seetharamkandarpa.webnode.in/news/no-acceptance-testing-during-method-transfer-cited-in-fda-483/https://seetharamkandarpa.webnode.in/news/new-publication-on-recent-developments-of-biosimilar-products/https://seetharamkandarpa.webnode.in/news/fda-483-observation-caused-by-wrong-sop-for-method-transfer/https://seetharamkandarpa.webnode.in/news/who-publishes-draft-on-revised-process-validation-guideline-validation-life-cycle-required/https://seetharamkandarpa.webnode.in/news/fda-publishes-gmp-requirements-for-combination-products/https://seetharamkandarpa.webnode.in/news/comparison-of-eu-gmp-and-indian-gmp-requirements-for-apis/https://seetharamkandarpa.webnode.in/news/written-confirmations-questions-answers-document-version-4-1-published-/https://seetharamkandarpa.webnode.in/news/revision-of-the-eu-gmp-guide-eu-commission-proposal-for-chapter-6-quality-control/https://seetharamkandarpa.webnode.in/news/fda-offers-elearning-for-ectd-implementation/https://seetharamkandarpa.webnode.in/news/brazils-gmp-guideline-available-in-english/https://seetharamkandarpa.webnode.in/news/written-confirmation-australia-gets-on-the-list-of-third-countries/https://seetharamkandarpa.webnode.in/news/dry-heat-sterilization-new-usp-general-chapter-1229-8-/https://seetharamkandarpa.webnode.in/news/handling-of-apis-and-excipients-new-guidelines-in-chapter-5-of-eu-gmp-guide/https://seetharamkandarpa.webnode.in/news/ema-issues-draft-guideline-on-similar-biological-medicinal-products-for-public-consultation/https://seetharamkandarpa.webnode.in/news/ranbaxy-pleads-guilty-and-pays-500-million-fine-/https://seetharamkandarpa.webnode.in/news/fda-addresses-retention-of-internal-audit-reports/https://seetharamkandarpa.webnode.in/news/a-major-mistake-that-managers-make-/https://seetharamkandarpa.webnode.in/news/mhra-conclusion-on-new-requirements-for-active-substances-imported-into-the-european-economic-area/https://seetharamkandarpa.webnode.in/news/fda-two-new-q-as-published-for-investigational-drugs/https://seetharamkandarpa.webnode.in/news/canada-gmp-requirements-now-applicable-to-all-apis/https://seetharamkandarpa.webnode.in/news/half-year-report-2013-fda-medical-devices-warning-letter-statistics-2-new-deficiency-group-in-the-top-5/https://seetharamkandarpa.webnode.in/news/incredible-and-alarming-gmp-violations-/https://seetharamkandarpa.webnode.in/news/gmp-audits-of-manufacturers-of-active-substances-minimum-requirements-on-audit-reports-and-qualification-of-auditors/https://seetharamkandarpa.webnode.in/news/mhra-implements-new-software-for-risk-based-inspection-planning/https://seetharamkandarpa.webnode.in/news/who-guideline-on-quality-risk-management-finalised/https://seetharamkandarpa.webnode.in/news/guideline-on-the-european-drug-master-file-procedure-updated/https://seetharamkandarpa.webnode.in/news/usp-expert-answers-questions-regarding-particulate-matter-testing/https://seetharamkandarpa.webnode.in/news/final-ema-variations-guideline-on-procedures-issues-and-classification-of-variations-published/https://seetharamkandarpa.webnode.in/news/who-publishes-variations-guideline-for-prequalified-apis-and-medicinal-products/https://seetharamkandarpa.webnode.in/news/new-who-initiative-good-pharmacopoeial-practices/https://seetharamkandarpa.webnode.in/news/eu-gmp-new-annex-16-released/https://seetharamkandarpa.webnode.in/news/biological-products-human-blood-and-blood-components-intended-for-transfusion-or-for-further-manufacture/https://seetharamkandarpa.webnode.in/news/new-fda-guideline-on-quality-of-heparin/https://seetharamkandarpa.webnode.in/news/written-confirmation-a-questions-answer-document-of-the-danish-authority-provides-further-clarifications/https://seetharamkandarpa.webnode.in/news/new-ema-inspection-requirements-on-good-distribution-practices-gdp-/https://seetharamkandarpa.webnode.in/news/new-requirements-of-the-fda-on-stability-testing-of-generic-drugs/https://seetharamkandarpa.webnode.in/news/variations-important-changes-in-the-new-application-form/https://seetharamkandarpa.webnode.in/news/cdsco-publishes-more-than-200-written-confirmations-for-apis-from-india/https://seetharamkandarpa.webnode.in/news/denying-delaying-and-refusing-how-to-fail-a-fda-inspection/https://seetharamkandarpa.webnode.in/news/draft-guideline-ich-q3d-for-elemental-impurities-published-/https://seetharamkandarpa.webnode.in/news/new-ema-guideline-on-starting-materials-from-biological-medicinal-products/https://seetharamkandarpa.webnode.in/news/updated-procedure-for-the-renewal-and-revision-of-ceps-/https://seetharamkandarpa.webnode.in/news/plair-new-fda-guideline-regulates-import-of-non-approved-drugs-in-the-run-up-to-the-launch-in-us/https://seetharamkandarpa.webnode.in/news/sun-pharma-to-pay-rs-2517-crore-to-settle-patent-suit/https://seetharamkandarpa.webnode.in/news/fda-releases-guidance-on-quality-agreements-for-contract-manufacturing/https://seetharamkandarpa.webnode.in/news/new-stimuli-article-on-method-development-performance-qualification-and-performance-verification/https://seetharamkandarpa.webnode.in/news/fda-issues-guidance-for-industry-on-risk-based-monitoring/https://seetharamkandarpa.webnode.in/news/fdas-special-agents-criminal-investigators/https://seetharamkandarpa.webnode.in/news/roche-to-invest-105m-into-training-center/https://seetharamkandarpa.webnode.in/news/new-draft-guidance-cosmetic-good-manufacturing-practices/https://seetharamkandarpa.webnode.in/news/woodens-pyramid-of-success-john-woodens-pyramid-of-success/https://seetharamkandarpa.webnode.in/news/gmp-and-quality-responsibility-integrity-and-accountability-article/https://seetharamkandarpa.webnode.in/news/who-revises-gmp-guide-regarding-the-principles-of-gmp/https://seetharamkandarpa.webnode.in/news/efpia-what-medicinal-product-manufacturers-need-to-know-about-the-european-verification-system-emvs/https://seetharamkandarpa.webnode.in/news/frequently-asked-gmp-question-how-to-reduce-testing-and-comply-with-gmp-/https://seetharamkandarpa.webnode.in/news/new-fda-guidance-on-the-finalization-of-several-fda-draft-guidances/https://seetharamkandarpa.webnode.in/news/fda-inspection-reports-what-are-various-results-and-their-significance-/https://seetharamkandarpa.webnode.in/news/who-revises-guideline-for-maximum-hold-times/https://seetharamkandarpa.webnode.in/news/interesting-apic-cefic-guideline-for-the-qualification-of-contract-laboratories/https://seetharamkandarpa.webnode.in/news/who-should-review-batch-record-/https://seetharamkandarpa.webnode.in/news/fda-scientists-link-transfused-uvb-irradiated-platelets-with-acute-lung-injury/https://seetharamkandarpa.webnode.in/news/fda-publishes-guidance-for-industry-blood-establishment-computer-system-validation-in-the-users-facility/https://seetharamkandarpa.webnode.in/news/ema-guideline-on-the-use-of-bovine-serum-in-the-manufacture-of-human-biological-medicinal-products/https://seetharamkandarpa.webnode.in/news/efpia-selects-microsoft-cloud-platform-for-the-european-verification-system-against-counterfeit-medicines/https://seetharamkandarpa.webnode.in/news/changes-in-the-edqm-cep-database/https://seetharamkandarpa.webnode.in/news/frequently-asked-gmp-question-how-should-active-substance-auditors-be-qualified-/https://seetharamkandarpa.webnode.in/news/eu-gmp-guide-final-chapter-2-on-personnel-published/https://seetharamkandarpa.webnode.in/news/fda-publishes-guidance-on-clinical-trials/https://seetharamkandarpa.webnode.in/news/successor-organisation-imdrf-of-the-ghtf/https://seetharamkandarpa.webnode.in/news/new-fda-guidelines-for-medical-devices/https://seetharamkandarpa.webnode.in/news/ema-publishes-guideline-on-pharmaceutical-development-of-medicines-for-paediatric-use/https://seetharamkandarpa.webnode.in/news/quality-by-design-lessons-learnt-from-ema-fda-pilot-program/https://seetharamkandarpa.webnode.in/news/fda-guide-on-import-of-drugs-prior-to-approval/https://seetharamkandarpa.webnode.in/news/black-triangle-a-new-eu-requirement/https://seetharamkandarpa.webnode.in/news/u-s-government-shutdown-consequences-for-the-fda/https://seetharamkandarpa.webnode.in/news/usp-draft-of-a-newly-proposed-chapter-1115-bioburden-control-of-nonsterile-drug-substances-and-products/https://seetharamkandarpa.webnode.in/news/u-s-fda-clearance-for-mass-spectrometry/https://seetharamkandarpa.webnode.in/news/new-fda-requirements-on-labelling-and-container-labels/https://seetharamkandarpa.webnode.in/news/new-fda-requirement-on-the-handling-of-inds/https://seetharamkandarpa.webnode.in/news/fda-publishes-current-list-of-drug-master-files-type-ii-/https://seetharamkandarpa.webnode.in/news/new-mhras-webpage-on-the-falsified-medicines-directive/https://seetharamkandarpa.webnode.in/news/qualification-requalification-frequent-obscurities/https://seetharamkandarpa.webnode.in/news/cleaning-validation-requirements-in-asia/https://seetharamkandarpa.webnode.in/news/fda-publishes-revised-guidance-for-applicants-of-marketing-authorisations-for-generics/https://seetharamkandarpa.webnode.in/news/revision-of-usp-chapter-on-ir-spectroscopy/https://seetharamkandarpa.webnode.in/news/fda-published-guideline-draft-on-the-registration-of-production-sites/https://seetharamkandarpa.webnode.in/news/ema-published-concept-paper-on-the-revision-of-the-finished-dosage-form-guideline/https://seetharamkandarpa.webnode.in/news/sister-file-procedure-new-fast-track-procedure-for-the-application-of-further-ceps-for-the-same-api/https://seetharamkandarpa.webnode.in/news/authorisation-of-generic-drugs-in-the-usa-requirements-on-apis-stability-data-for-us-drug-master-files/https://seetharamkandarpa.webnode.in/news/stability-testing-of-generics-fda-publishes-q-a-document/https://seetharamkandarpa.webnode.in/news/ema-guideline-on-quality-of-biological-active-substances-produced-by-transgene-expression-in-animals/https://seetharamkandarpa.webnode.in/news/a1997-2003-2013-quo-vadis-21-cfr-11-/https://seetharamkandarpa.webnode.in/news/ema-publishes-revised-dossier-submission-requirements-for-active-substance-master-files/https://seetharamkandarpa.webnode.in/news/fda-launched-secure-supply-chain-pilot-program/https://seetharamkandarpa.webnode.in/news/who-publishes-revised-draft-on-gtdp-for-pharmaceutical-starting-material/https://seetharamkandarpa.webnode.in/news/overview-of-the-requirements-on-wfi-in-the-eu-usa-and-japan/https://seetharamkandarpa.webnode.in/news/new-fda-fees-for-drug-master-files-published/https://seetharamkandarpa.webnode.in/news/revision-of-the-usp-chapter-on-packaging-and-storage-requirements-659-/https://seetharamkandarpa.webnode.in/news/usp-visual-inspection-expert-answers-for-question-regarding-aql-testing/https://seetharamkandarpa.webnode.in/news/asean-countries-published-draft-of-a-guideline-on-process-validation/https://seetharamkandarpa.webnode.in/news/dun-and-bradstreet-verification-in-the-eu-site-master-file-/https://seetharamkandarpa.webnode.in/news/fda-is-proposing-a-regulation-to-implement-administrative-detention-authority-during-inspections/https://seetharamkandarpa.webnode.in/news/zydus-germanys-pieris-tie-up-to-develop-anticalin-protein-drugs-/https://seetharamkandarpa.webnode.in/news/teva-pharmaceutical-to-cut-5-000-jobs-save-2-bn-annually-/https://seetharamkandarpa.webnode.in/news/usfda-increases-inspection-staff-in-india/https://seetharamkandarpa.webnode.in/news/article-on-the-consequences-of-non-compliance/https://seetharamkandarpa.webnode.in/news/usfda-draft-guidance-circumstances-that-constitute-delaying-denying-limiting-or-refusing-a-drug-inspection/https://seetharamkandarpa.webnode.in/news/article-are-funny-people-more-successful-in-business-forbes-article-/https://seetharamkandarpa.webnode.in/news/fda-warning-for-inadequate-storage-of-reference-samples-and-reagents/https://seetharamkandarpa.webnode.in/news/srk-gmp-ocean-my-android-application/https://seetharamkandarpa.webnode.in/news/european-medicines-agency-and-us-food-and-drug-administration-release-further-guidance-on-quality-by-design-approach/https://seetharamkandarpa.webnode.in/news/revised-annex-16-comments-of-the-european-qp-association/https://seetharamkandarpa.webnode.in/news/updates-from-the-us-on-particles-in-injectables/https://seetharamkandarpa.webnode.in/news/new-q-a-document-of-the-cmdh-gives-answers-to-essential-questions-on-the-asmf-procedure/https://seetharamkandarpa.webnode.in/news/european-qp-association-initiated-a-database-comprising-shared-audits-information/https://seetharamkandarpa.webnode.in/news/usp-proposes-chapter-on-assessment-of-drug-product-leachables-associated-with-pharmaceutical-packaging-delivery-systems/https://seetharamkandarpa.webnode.in/news/fda-published-list-of-gmp-facilities-producing-for-the-us-market-generic-drug-products-and-apis-/https://seetharamkandarpa.webnode.in/news/new-fda-requirement-on-the-handling-of-inds1/https://seetharamkandarpa.webnode.in/news/j-j-merck-kgaa-move-forward-with-new-china-investments/https://seetharamkandarpa.webnode.in/news/gsk-expanding-further-in-india-with-%c2%a385m-facility%2c-ceo-witty-says/https://seetharamkandarpa.webnode.in/news/pharma-in-india-scrambles-to-appease-wholesalers-chemists/https://seetharamkandarpa.webnode.in/news/actavis-to-close-nc-plant-trim-310-jobs/https://seetharamkandarpa.webnode.in/news/test/https://seetharamkandarpa.webnode.in/news/new-usp-requirements-for-pharmaceutical-packaging-materials-and-international-standards-for-the-measurement-of-material-permeability-indexes/https://seetharamkandarpa.webnode.in/news/ich-reviews-future-ich-topics-and-its-organisation/https://seetharamkandarpa.webnode.in/news/fda-science-and-research-keeping-stored-platelets-free-of-bacteria/https://seetharamkandarpa.webnode.in/news/risk-assessment-for-ascertaining-gmp-for-excipients/https://seetharamkandarpa.webnode.in/news/guidelines-on-gdp-eu-revised/https://seetharamkandarpa.webnode.in/news/revision-of-the-eu-gmp-guide-eu-commission-publishes-comments-for-chapters-3-5-6-and-8/https://seetharamkandarpa.webnode.in/news/perspectives-on-the-pqri-extractables-and-leachables-safety-thresholds-and-best-practices-recommendations-for-inhalation-drug-products/https://seetharamkandarpa.webnode.in/news/fda-publishes-guidance-for-industry-on-investigation-device-exemptions/https://seetharamkandarpa.webnode.in/news/new-developments-in-the-eu-with-regard-to-medical-devices/https://seetharamkandarpa.webnode.in/news/fda-will-participate-in-a-medical-devices-single-audit-pilot-programme-in-2014/https://seetharamkandarpa.webnode.in/news/updates-on-medical-device-regulations/https://seetharamkandarpa.webnode.in/news/mumbai-pharma-summit-to-honour-excellence-promote-ethics/https://seetharamkandarpa.webnode.in/news/torrent-buys-elders-domestic-business-keeping-it-indian-controlled/https://seetharamkandarpa.webnode.in/news/boston-scientifics-watchman-stroke-fighting-device-wins-overwhelming-fda-panel-support/https://seetharamkandarpa.webnode.in/news/china-arrests-1-300-people-suspected-of-making-and-selling-fake-medicines/https://seetharamkandarpa.webnode.in/news/most-frequent-fda-483-observations-fiscal-year-2012/https://seetharamkandarpa.webnode.in/news/maco-calculation-sheet-in-cleaning-validation/https://seetharamkandarpa.webnode.in/news/my-new-mobile-application-srk-cleaning-validation/https://seetharamkandarpa.webnode.in/news/gmp-for-radiopharmaceuticals-existing-and-expected-guidelines/https://seetharamkandarpa.webnode.in/news/usp-proposal-on-temperature-control-during-storage-and-distribution/https://seetharamkandarpa.webnode.in/news/ema-now-also-issues-gmp-and-gdp-non-compliance-information/https://seetharamkandarpa.webnode.in/news/summary-of-the-new-eu-gmp-chapters-and-annexes/https://seetharamkandarpa.webnode.in/news/european-qp-association-new-q-as-published/https://seetharamkandarpa.webnode.in/news/implementation-of-good-distribution-practices-explanatory-notes-from-mhra/https://seetharamkandarpa.webnode.in/news/fda-2013-review/https://seetharamkandarpa.webnode.in/news/good-practice-guidelines-for-blood-establishments-as-a-co-operation-between-the-edqm-coe-and-the-eu-commission-published/https://seetharamkandarpa.webnode.in/news/how-to-submit-an-active-substance-master-file-/https://seetharamkandarpa.webnode.in/news/update-electronic-submission-of-marketing-authorisation-dossiers/https://seetharamkandarpa.webnode.in/news/reception-denied-the-new-fda-refuse-to-receive-guidance-for-generics-applications/https://seetharamkandarpa.webnode.in/news/more-inspections-by-usfda-in-2014/https://seetharamkandarpa.webnode.in/news/gcp-and-bioequivalence-studies-new-fda-ema-initiative/https://seetharamkandarpa.webnode.in/news/new-fda-guidance-for-drug-development-tools/https://seetharamkandarpa.webnode.in/news/new-ema-guidance-qualification-of-novel-methodologies-for-drug-development/https://seetharamkandarpa.webnode.in/news/mhra-good-pharmacovigilance-practice-compliance-report-template-now-available/https://seetharamkandarpa.webnode.in/news/eli-lilly-provides-statement-in-response-to-sanofi-us-lawsuit/https://seetharamkandarpa.webnode.in/news/novartis-to-cut-or-transfer-up-to-4-000-pharma-jobs-/https://seetharamkandarpa.webnode.in/news/pfizers-new-breast-cancer-drug-succeeds-in-trial-/https://seetharamkandarpa.webnode.in/news/fda-commissioner-speaks-out-on-innovation/https://seetharamkandarpa.webnode.in/news/mhra-press-release-the-british-pharmacopoeia-celebrates-its-150th-birthday/https://seetharamkandarpa.webnode.in/news/usp-proposed-to-revise-the-general-chapter-1092-on-dissolution/https://seetharamkandarpa.webnode.in/news/new-presentation-on-future-activities-of-ich-from-the-fda-point-of-view/https://seetharamkandarpa.webnode.in/news/my-new-mobile-application-srk-gmp-videos/https://seetharamkandarpa.webnode.in/news/white-pape-on-raising-quality-results-on-supplier-audits-using-eqms-for-pharmaceutical-companies/https://seetharamkandarpa.webnode.in/news/eudragmdp-database-gdp-certificates/https://seetharamkandarpa.webnode.in/news/gmp-inspections-enhanced-international-collaboration/https://seetharamkandarpa.webnode.in/news/draft-eu-gmp-annex-15-for-qualification-and-validation-published/https://seetharamkandarpa.webnode.in/news/my-new-mobile-application-srk-gcp-world/https://seetharamkandarpa.webnode.in/news/new-process-validation-guideline-by-ema/https://seetharamkandarpa.webnode.in/news/personal-overview-of-fda-commissioner-margaret-a-hamburg-about-visit-in-india/https://seetharamkandarpa.webnode.in/news/japanese-pharmacopoeia-and-japanese-gmp-regulations-online/https://seetharamkandarpa.webnode.in/news/new-guidance-on-validation-of-analytical-methods-by-usfda/https://seetharamkandarpa.webnode.in/news/fda-secure-supply-chain-pilot-program-13-companies-prequalified/https://seetharamkandarpa.webnode.in/news/a2010-2011-gcp-inspection-metrics-report-published-by-mhra/https://seetharamkandarpa.webnode.in/news/balances-correction-of-the-requirements-in-the-u-s-pharmacopoeia-usp-/https://seetharamkandarpa.webnode.in/news/revision-of-the-usp-chapter-on-spectroscopic-methods-/https://seetharamkandarpa.webnode.in/news/new-usp-proposal-for-optimised-method-of-measuring-moisture-vapour-permeation-related-to-pharmaceutical-packaging/https://seetharamkandarpa.webnode.in/news/new-ema-guideline-on-stability-testing-for-applications-for-variations/https://seetharamkandarpa.webnode.in/news/dissolution-testing-planned-revision-of-the-usp-chapter/https://seetharamkandarpa.webnode.in/news/another-fda-import-alert-for-an-indian-manufacturer-due-to-gmp-problems/https://seetharamkandarpa.webnode.in/news/ema-changes-to-handling-of-variations/https://seetharamkandarpa.webnode.in/news/fda-wants-to-increase-number-of-foreign-inspections/https://seetharamkandarpa.webnode.in/news/new-fda-guidance-to-avoid-overfill-of-vials/https://seetharamkandarpa.webnode.in/news/new-eu-gmp-guide-chapter-6/https://seetharamkandarpa.webnode.in/news/integrity-and-security-of-medicinal-products-supply-chains-new-instructions-in-the-us-american-pharmacopeia-usp-/https://seetharamkandarpa.webnode.in/news/combined-risk-assessment-for-analytical-instruments-and-computer-systems-in-the-laboratory/https://seetharamkandarpa.webnode.in/news/how-does-the-edqm-process-cep-applications-a-new-policy-provides-information/https://seetharamkandarpa.webnode.in/news/new-fda-guideline-on-size-shape-and-physical-attributes-of-generics/https://seetharamkandarpa.webnode.in/news/overview-of-new-cdrh-guidelines/https://seetharamkandarpa.webnode.in/news/fda-plans-changes-to-the-classification-of-medical-devices/https://seetharamkandarpa.webnode.in/news/fda-published-medical-device-recall-report/https://seetharamkandarpa.webnode.in/news/fda-published-guidance-for-industry-on-investigation-device-exemptions-ide-/https://seetharamkandarpa.webnode.in/news/edqm-database-on-counterfeit-falsified-medicinal-products/https://seetharamkandarpa.webnode.in/news/who-published-revised-draft-on-the-guideline-on-hold-time-studies/https://seetharamkandarpa.webnode.in/news/cmc-postapproval-manufacturing-changes-to-be-documented-in-annual-reports-new-fda-guidance/https://seetharamkandarpa.webnode.in/news/question-answer-document-on-gdp-by-european-commission-/https://seetharamkandarpa.webnode.in/news/draft-guideline-on-validation-of-biotechnology-derived-products-by-ema/https://seetharamkandarpa.webnode.in/news/new-rules-for-clinical-trials-conducted-in-the-eu-questions-answers-/https://seetharamkandarpa.webnode.in/news/allergen-manufacturer-warned-for-unapproved-drugs-insect-infestation/https://seetharamkandarpa.webnode.in/news/electronic-submissions-presentations-by-usfda/https://seetharamkandarpa.webnode.in/news/anda-checklist-for-completeness-and-acceptability/https://seetharamkandarpa.webnode.in/news/qualification-of-a-responsible-person-for-gdp-uk-gold-standard/https://seetharamkandarpa.webnode.in/news/organic-impurities-testing-usp-plans-extensive-revision-of-general-chapters-and-monographs/https://seetharamkandarpa.webnode.in/news/draft-on-process-validation-by-who/https://seetharamkandarpa.webnode.in/news/us-fda-guidance-for-industry-andas-stability-testing-of-drug-substances-and-products-and-fda-questions-and-answers/https://seetharamkandarpa.webnode.in/news/ema-official-details-obstacles-to-reaching-mutual-reliance-on-gmp-inspections/https://seetharamkandarpa.webnode.in/news/sun-pharma-gets-warning-letter-from-usfda/https://seetharamkandarpa.webnode.in/news/pic-s-committee-has-adopted-a-guide-on-good-distribution-practice-gdp-/https://seetharamkandarpa.webnode.in/news/indian-government-to-spend-rs-3-000-crore-to-strengthen-drug-regulatory/https://seetharamkandarpa.webnode.in/news/fda-issues-final-guidance-on-considerations-when-transferring-clinical-investigation-oversight-to-another-irb/https://seetharamkandarpa.webnode.in/news/fda-warns-german-drugmaker-for-potentially-contaminating-products/https://seetharamkandarpa.webnode.in/news/mylan-launches-atovaquone-proguanil-hydrochloride-tablets/https://seetharamkandarpa.webnode.in/news/health-drug-to-remain-under-administrative-control-of-two-ministries-despite-streamlining-process-by-modi-govt/https://seetharamkandarpa.webnode.in/news/seetharam-kandarpa-receives-asq-certified-pharmaceutical-gmp-professional/https://seetharamkandarpa.webnode.in/news/hmpc-q-a-documents-on-herbal-medicinal-products/https://seetharamkandarpa.webnode.in/news/guidelines-on-requirements-and-expectations-for-the-qualified-person-in-a-pharmaceutical-company-by-dhma/https://seetharamkandarpa.webnode.in/news/final-qp-declaration-template-by-ema/https://seetharamkandarpa.webnode.in/news/guidance-on-cleaning-validation-in-active-pharmaceutical-ingredients-plants-by-apic/https://seetharamkandarpa.webnode.in/news/important-judgement-in-the-gmp-world-eu-commission-entitled-to-take-far-reaching-decisions-when-gmp-deviations-are-found/https://seetharamkandarpa.webnode.in/news/particles-continue-to-cause-major-compliance-problems-and-recalls/https://seetharamkandarpa.webnode.in/news/new-procedure-for-co-ordinating-gcp-inspections-by-chmp/https://seetharamkandarpa.webnode.in/news/fda-launches-openfda-to-provide-easy-access-to-valuable-fda-public-data/https://seetharamkandarpa.webnode.in/news/indias-data-integrity-problems/https://seetharamkandarpa.webnode.in/news/regulators-again-find-data-integrity-problems-at-indian-manufacturing-site/https://seetharamkandarpa.webnode.in/news/death-by-prescription-painkiller/https://seetharamkandarpa.webnode.in/news/adverse-drug-reactions-e-modules/https://seetharamkandarpa.webnode.in/news/fake-antibiotics-feed-growing-worldwide-superbugs-threat/https://seetharamkandarpa.webnode.in/news/class-2-medicines-recall-action-within-48-hours-clarithromycin-500mg-powder-for-solution-for-infusion-in-agila-livery-manufactured-strides-arcolab-international-limited-el-14-a-07-/https://seetharamkandarpa.webnode.in/news/medical-device-news-microwave-helmet-can-spot-a-stroke/https://seetharamkandarpa.webnode.in/news/complimentary-life-sciences-guidebook-best-practices-for-fda-compliance-software-solutions/https://seetharamkandarpa.webnode.in/news/seetharam-kandarpa-receives-asq-quality-auditor/https://seetharamkandarpa.webnode.in/news/elemental-impurities-ich-q3d-has-reached-step-4-final-guideline-/https://seetharamkandarpa.webnode.in/news/delegated-regulation-on-gmp-for-apis-published-in-the-official-journal-of-the-eu/https://seetharamkandarpa.webnode.in/news/usfda-warning-letter-to-novacyl-wuxi-pharmaceutical-co-ltd-12-19-14/https://seetharamkandarpa.webnode.in/news/usfda-inspections-483s-dashboard/https://seetharamkandarpa.webnode.in/news/gmp-non-compliance-reports-agepha-austria-published-by-ema/https://seetharamkandarpa.webnode.in/news/gmp-non-compliance-reports-north-china-pharmaceutical-group-semisyntech-co-ltd-china-published-by-ema-/https://seetharamkandarpa.webnode.in/news/usfda-483s-published-in-2014-by-usfda/https://seetharamkandarpa.webnode.in/news/iso-9001-2008-quality-management-systems-requirements/https://seetharamkandarpa.webnode.in/news/good-manufacturing-practice-data-integrity-definitions-by-mhra/https://seetharamkandarpa.webnode.in/news/concept-paper-on-the-revision-of-eu-gmp-annex-1-manufacture-of-sterile-medicinal-products/https://seetharamkandarpa.webnode.in/news/fda-commissioner-margaret-hamburg-to-resign-next-month/https://seetharamkandarpa.webnode.in/news/mhra-warns-of-people-impersonating-its-staff-/https://seetharamkandarpa.webnode.in/news/man-gets-3-year-prison-sentence-for-fake-drug-study/https://seetharamkandarpa.webnode.in/news/usfda-warning-letters-updates/https://seetharamkandarpa.webnode.in/news/eudralex-v30-january-2015/https://seetharamkandarpa.webnode.in/news/final-eu-gmp-annex-15-qualification-validation-effective-from-01-october-2015/https://seetharamkandarpa.webnode.in/news/gmp-pre-inspection-compliance-documents-published-by-mhra/https://seetharamkandarpa.webnode.in/news/eu-commission-released-two-final-guidelines-on-gmp-for-excipients-and-gdp-for-apis/https://seetharamkandarpa.webnode.in/news/new-guidance-on-environmental-assessments-for-biotechnology-products-by-usfda/https://seetharamkandarpa.webnode.in/news/revision-of-gmp-data-integrity-definitions-from-mhra/https://seetharamkandarpa.webnode.in/news/health-canada-vanessas-law-effective-from-november-2014/https://seetharamkandarpa.webnode.in/news/tga-finalised-the-specificationfor-the-australian-ectd-format-submissions/https://seetharamkandarpa.webnode.in/news/health-canada-launched-new-drug-and-product-inspections-database/https://seetharamkandarpa.webnode.in/news/who-called-for-increased-transparency-in-medical-research/https://seetharamkandarpa.webnode.in/news/indian-government-to-amend-schedule-y-of-d-c-rules-pertaining-to-authenticity-of-data-submitted-by-applicants/https://seetharamkandarpa.webnode.in/news/fda-warns-consumers-not-to-use-muscle-growth-product-called-tri-methyl-xtreme/https://seetharamkandarpa.webnode.in/news/fdas-new-pharmaceutical-quality-approach-one-quality-voice/https://seetharamkandarpa.webnode.in/news/u-s-marshals-seize-unapproved-drugs-from-florida-distributor/https://seetharamkandarpa.webnode.in/news/fda-and-cms-form-task-force-on-ldt-quality-requirements/https://seetharamkandarpa.webnode.in/news/usfda-guidance-on-anda-submissions-refuse-to-receive-standards-effective-from-26-may-2015/https://seetharamkandarpa.webnode.in/news/usfda-draft-guidance-on-conditions-reportable-cmc-changes-for-approved-drug-and-biologic-products-effective-from-29-may-2015/https://seetharamkandarpa.webnode.in/news/new-who-trs-992-may-2015-having-guidance-on-hold-time-study-process-validationand-stirage-transport-of-products/https://seetharamkandarpa.webnode.in/news/notice-by-cdsco-regarding-administrative-action-by-concerned-licensing-authority-dated-04-06-2015/https://seetharamkandarpa.webnode.in/news/new-draft-guidance-from-usfda-on-request-for-quality-metrics/https://seetharamkandarpa.webnode.in/news/new-final-guidance-from-usfda-related-to-pharmaceutical-quality-cmc-on-analytical-procedures-and-methods-validation-for-drugs-and-biologics/https://seetharamkandarpa.webnode.in/news/usfda-published-a-final-rule-fda-2011-n-0898-permanent-discontinuance-or-interruption-in-manufacturing-of-certain-drug-or-biological-products/https://seetharamkandarpa.webnode.in/news/update-of-guideline-on-the-packaging-information-of-medicinal-products-for-human-use-authorised-by-the-union-july-2015-eudralex-volume-2/https://seetharamkandarpa.webnode.in/news/non-compliance-reports-published-by-eudra-gmdp/https://seetharamkandarpa.webnode.in/news/quality-metrics-industry-reaction-to-fdas-draft-guidance/https://seetharamkandarpa.webnode.in/news/edqm-released-new-edition-of-technical-guide-for-the-elaboration-of-monographs/https://seetharamkandarpa.webnode.in/news/apic-revised-the-how-to-do-document-on-ich-q7/https://seetharamkandarpa.webnode.in/news/new-gmp-implementing-act-published-by-eu/https://seetharamkandarpa.webnode.in/news/consultation-on-eu-gmp-guidelines-revised-annex-17-on-the-real-time-release-testing/https://seetharamkandarpa.webnode.in/news/european-medicines-agency-pre-authorisation-procedural-advice-for-users-of-the-centralised-procedure/https://seetharamkandarpa.webnode.in/news/who-draft-on-supplementary-guidelines-on-gmp-for-hvac-systems-for-non-sterile-pharmaceutical-dosage-forms/https://seetharamkandarpa.webnode.in/news/ipec-federation-published-position-paper-on-third-party-audit-and-certification-programmes/https://seetharamkandarpa.webnode.in/news/training-presentation-on-how-to-conduct-an-effective-internal-quality-audit/https://seetharamkandarpa.webnode.in/news/training-presentation-on-ich-q10-pharmaceutical-quality-system/https://seetharamkandarpa.webnode.in/news/training-presentation-on-ich-q9-quality-risk-management/https://seetharamkandarpa.webnode.in/news/reflection-paper-on-the-chemical-structure-and-properties-criteria-to-be-considered-for-the-evaluation-of-new-active-substance-nas-status-of-chemical-substances/https://seetharamkandarpa.webnode.in/news/iso-14644-part-1-final-version-on-cleanroom-classification/https://seetharamkandarpa.webnode.in/news/best-practice-guide-for-quality-agreements-published/https://seetharamkandarpa.webnode.in/news/packaging-pharmeuropa-draft-chapters-regarding-pvc/https://seetharamkandarpa.webnode.in/news/gcp-implementing-regulation-on-inspection-procedures/https://seetharamkandarpa.webnode.in/news/ema-revises-guide-on-pharmaceutical-water/https://seetharamkandarpa.webnode.in/news/recognition-of-alternative-compendia-bp-ep-jp-by-the-fda/https://seetharamkandarpa.webnode.in/news/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp-18-21-april-2017/https://seetharamkandarpa.webnode.in/news/regulatory-information-adjusted-fees-for-applications-to-ema-from-1-april-2017/https://seetharamkandarpa.webnode.in/news/mhras-interpretation-of-cross-contamination-pdes/https://seetharamkandarpa.webnode.in/news/ema-q-a-on-gcp/https://seetharamkandarpa.webnode.in/news/mentoring-class-for-asq-cqa-and-asq-cpgp/https://seetharamkandarpa.webnode.in/news/the-value-of-an-asq-certification/https://seetharamkandarpa.webnode.in/news/download-the-quality-auditor-certification-brochure/https://seetharamkandarpa.webnode.in/news/requirements/https://seetharamkandarpa.webnode.in/news/the-certified-quality-auditor-body-of-knowledge/https://seetharamkandarpa.webnode.in/news/examination/https://seetharamkandarpa.webnode.in/news/recertification/https://seetharamkandarpa.webnode.in/news/list-of-references/https://seetharamkandarpa.webnode.in/news/sample-exam/https://seetharamkandarpa.webnode.in/news/the-asq-auditing-handbook-fourth-edition/https://seetharamkandarpa.webnode.in/news/apply-now/https://seetharamkandarpa.webnode.in/news/mentoring-classes-for-asq-cqa/https://seetharamkandarpa.webnode.in/news/asq-cqa-exam-questions-vs-chapters-vs-level-of-cognition/https://seetharamkandarpa.webnode.in/news/quality-auditor-certification-cqa/https://seetharamkandarpa.webnode.in/news/mentoring-class-for-asq-cqa/https://seetharamkandarpa.webnode.in/news/web-series-session-1-overview-of-asq-certified-quality-auditor-conducted-on-21-may-2017/https://seetharamkandarpa.webnode.in/news/web-series-session-1-overview-of-asq-certified-quality-auditor-conducted-on-21-may-20171/https://seetharamkandarpa.webnode.in/news/coming-soon/https://seetharamkandarpa.webnode.in/news/overview-of-asq-certified-pharmaceutical-gmp-professional-cpgp/https://seetharamkandarpa.webnode.in/news/web-series-2-of-asq-cqa-mentoring-class-auditing-fundamentals-on-30-july-2017/https://seetharamkandarpa.webnode.in/news/privacy-policy/https://seetharamkandarpa.webnode.in/news/fda-publishes-revised-mapp-anda-suitability-petitions-5240-5/https://seetharamkandarpa.webnode.in/news/seetharam-kandarpa-receives-asq-certified-manager-of-quality-organizational-excellence/https://seetharamkandarpa.webnode.in/news/fda-allows-marketing-of-first-direct-to-consumer-app-for-contraceptive-use-to-prevent-pregnancy/https://seetharamkandarpa.webnode.in/news/fda-issues-final-guidance-entitled-dissolution-testing-and-acceptance-criteria-for-immediate-release-solid-oral-dosage-form-drug-products-containing-high-solubility-drug-substances/https://seetharamkandarpa.webnode.in/news/fda-launches-new-medication-guide-database-drug-information-update/https://seetharamkandarpa.webnode.in/news/brexit-preparedness-ema-to-further-temporarily-scale-back-and-suspend-activities/https://seetharamkandarpa.webnode.in/news/targeted-stakeholder-consultation-on-the-draft-guidelines-on-good-clinical-practice-for-advanced-therapy-medicinal-products/https://seetharamkandarpa.webnode.in/news/overview-of-iso-19011-2018-guidelines-for-auditing-management-systems/https://seetharamkandarpa.webnode.in/products/usfda-warning-letter/https://seetharamkandarpa.webnode.in/products/world-health-organization-public-inspection-reports-whopir-/https://seetharamkandarpa.webnode.in/products/gmp-regulations/https://seetharamkandarpa.webnode.in/products/product-1/https://seetharamkandarpa.webnode.in/products/apic-publications-active-pharmaceutical-ingredients-committee/https://seetharamkandarpa.webnode.in/products/who-guidelines/https://seetharamkandarpa.webnode.in/products/who-basic-training-modules-on-good-manufacturing-practices-gmp-/https://seetharamkandarpa.webnode.in/products/video-on-phases-of-pharmaceutical-industry/https://seetharamkandarpa.webnode.in/products/video-on-tablet-manufacturing-process/https://seetharamkandarpa.webnode.in/products/g-one/https://seetharamkandarpa.webnode.in/products/bloggs-joe/